Protagonist Therapeutics PTGX
NASDAQ PTGX
$145.65 -3.15 (-2.12%)
As of: Sep 4, 2026 · 3:59 PM EDT

Protagonist Therapeutics (PTGX) Net Margin (QoQ) (2017 - 2026)

Analysis

Protagonist Therapeutics (PTGX) Net Margin (QoQ) (2017 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Protagonist Therapeutics 9.61 Bn 9.61 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6,956.00
Mar 31, 2026 23,313.00
Dec 31, 2025 60,845.00
Sep 30, 2025 -20,741.00
Jun 30, 2025 -58,631.00
Mar 31, 2025 -8,795.00
Dec 31, 2024 75,717.00
Sep 30, 2024 2,377.00
Jun 30, 2024 -81,547.00
Mar 31, 2024 -651.00
Jun 30, 2022 -446,958.00
Mar 31, 2022 34,974.00
Dec 31, 2021 -10,252.00
Sep 30, 2021 103,304.00
Jun 30, 2021 -97,393.00
Mar 31, 2021 5,674.00
Dec 31, 2020 -38,530.00
Sep 30, 2020 25,319.00
Jun 30, 2020 23,886.00
Mar 31, 2020 -132,626.00